CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ 1,181,427	$ (791,109)
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities -
Depreciation and Amortization	18,225	43,961
Gain on Sale of Patents	(2,276,286)
Gain on Sale of Assets	(9,457)	(32,883)
Stock-based Compensation Expense and Consulting Expense	52,160	15,361
Non-cash Interest Expense	28,958	45,000
Accounts Receivable, net	29,345	245,040
Inventories	(32,065)	(37,158)
Prepaid Expenses	(755)	(16,058)
Accounts Payable	(414,614)	226,905
Customer Advances	(13,673)	(65,076)
Accrued Expenses	123,466	(26,835)
Net Cash Used In Operating Activities	(1,313,269)	(392,852)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net Proceeds from Sale of Patents	2,463,171
Proceeds from Sale of Assets	9,457	32,883
Additional Patent Costs	(1,724)	(16,027)
Net Cash Provided By Investing Activities	2,470,904	16,856
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of principal and interest on 10% Senior Convertible Notes	(740,972)
Purchase of treasury stock (47,398 shares)		(474)
Net Cash Used In Financing Activities	(740,972)	(474)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	416,663	(376,470)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	19,556	416,040
CASH AND CASH EQUIVALENTS, END OF PERIOD	436,219	39,570
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash Paid for Income Taxes	912	912
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock to satisfy deferred compensation obligations (245,326 shares)	$ 674,645